Effects of County-Level Opioid Dispensing Rates on Individual-Level Patterns of Prescription Opioid and Heroin Consumption: Evidence From National U.S. Data.


Journal

The American journal of psychiatry
ISSN: 1535-7228
Titre abrégé: Am J Psychiatry
Pays: United States
ID NLM: 0370512

Informations de publication

Date de publication:
04 2022
Historique:
pubmed: 9 12 2021
medline: 5 4 2022
entrez: 8 12 2021
Statut: ppublish

Résumé

The authors examined directly whether county-level changes in opioid dispensing rates affect individual-level prescription opioid misuse, frequency of use, and dependence, as well as the same outcomes for heroin. Using data from the restricted-access National Survey on Drug Use and Health, the Centers for Disease Control and Prevention's retail opioid prescription database, the Prescription Drug Abuse Policy System, and the U.S. Census, the authors applied fixed-effects models to determine whether county-level dispensing rates affected prescription opioid outcomes as intended and whether changes in rates adversely affected heroin use outcomes. Bayes factors were used to confirm evidence for null findings. The sample included 748,800 respondents age 12 and older from 2006 to 2016. The odds of prescription opioid misuse, increased frequency of misuse, and dependence were 7.2%, 3.5%, and 10.4% higher, respectively, per standard deviation increase in the county-level opioid dispensing rate per 100 persons. There was no evidence for any association between opioid dispensing rates and the three heroin outcomes. The odds ratio was nonsignificant according to frequentist techniques in fixed-effects models, and Bayesian techniques confirmed very strong support for the null hypothesis. County-level opioid dispensing rates are directly associated with individual-level prescription opioid misuse, frequency of misuse, and dependence. Changes in dispensing were not associated with population shifts in heroin use. Reductions in opioid dispensing rates have contributed to stemming prior increases in prescription opioid misuse while not adversely affecting heroin use. Physicians and other health care providers can take action to minimize opioid dispensing for tangible benefits regarding prescription opioid misuse without adverse effects on heroin use.

Identifiants

pubmed: 34875874
doi: 10.1176/appi.ajp.2021.21060602
pmc: PMC8976704
mid: NIHMS1745010
doi:

Substances chimiques

Analgesics, Opioid 0
Heroin 70D95007SX

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

305-311

Subventions

Organisme : NIDA NIH HHS
ID : R21 DA046447
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

JAMA. 2017 Aug 1;318(5):425-426
pubmed: 28687823
Int J Drug Policy. 2014 Mar;25(2):257-66
pubmed: 24238956
J Pediatr. 2015 Sep;167(3):605-12.e1-2
pubmed: 26054942
N Engl J Med. 2015 Jan 15;372(3):241-8
pubmed: 25587948
N Engl J Med. 2016 Jul 7;375(1):44-53
pubmed: 27332619
Addict Behav. 2017 Jun;69:65-77
pubmed: 28152391
JAMA Psychiatry. 2014 Jul 1;71(7):821-6
pubmed: 24871348
Int J Drug Policy. 2019 Sep;71:183-188
pubmed: 30718120
Ann Intern Med. 2018 Jun 5;168(11):783-790
pubmed: 29801093
Health Aff (Millwood). 2016 Oct 1;35(10):1876-1883
pubmed: 27702962
Pain Physician. 2014 Mar-Apr;17(2):E119-28
pubmed: 24658483
Ann Intern Med. 2017 Sep 05;167(5):293-301
pubmed: 28761945
Drug Alcohol Depend. 2006 Feb 1;81(2):103-7
pubmed: 16023304
N Engl J Med. 2016 Jan 14;374(2):154-63
pubmed: 26760086
Am J Prev Med. 2006 Dec;31(6):506-11
pubmed: 17169712
JAMA. 2008 Dec 10;300(22):2613-20
pubmed: 19066381
Drug Alcohol Depend. 2016 Aug 01;165:1-8
pubmed: 27264166
Addiction. 2016 Dec;111(12):2230-2247
pubmed: 27347846
Clin J Pain. 2014 Jul;30(7):557-64
pubmed: 24281273
Pain Med. 2012 Dec;13(12):1580-9
pubmed: 23137228
BMC Health Serv Res. 2019 Nov 1;19(1):784
pubmed: 31675963
Ann Intern Med. 2010 Jan 19;152(2):85-92
pubmed: 20083827
Drug Alcohol Depend. 2013 Sep 1;132(1-2):95-100
pubmed: 23410617
MMWR Morb Mortal Wkly Rep. 2017 Jul 07;66(26):697-704
pubmed: 28683056
Drug Alcohol Rev. 2011 May;30(3):264-70
pubmed: 21545556
JAMA. 2011 Apr 6;305(13):1315-21
pubmed: 21467284
Pain Med. 2011 Apr;12(4):657-67
pubmed: 21392250
Health Aff (Millwood). 2016 Jun 1;35(6):1045-51
pubmed: 27269021
Am J Prev Med. 2021 Oct;61(4):537-544
pubmed: 34233856
Pain Med. 2012 Jan;13(1):87-95
pubmed: 22026451
Drug Alcohol Depend. 2020 Nov 1;216:108239
pubmed: 32854001
Drug Alcohol Depend. 2007 Oct 8;90(2-3):252-60
pubmed: 17513069
Drug Alcohol Depend. 2013 Sep 1;132(1-2):81-6
pubmed: 23399467
Am J Psychiatry. 2018 Mar 1;175(3):284
pubmed: 29490499
J Gen Intern Med. 2018 Sep;33(9):1512-1519
pubmed: 29948815
N Engl J Med. 2017 Jul 27;377(4):391-394
pubmed: 28564549
Science. 2018 Aug 10;361(6402):588-590
pubmed: 30093595

Auteurs

Mike Vuolo (M)

Department of Sociology, Ohio State University, Columbus (Vuolo); Department of Sociology, Purdue University, West Lafayette, Ind. (Kelly).

Brian C Kelly (BC)

Department of Sociology, Ohio State University, Columbus (Vuolo); Department of Sociology, Purdue University, West Lafayette, Ind. (Kelly).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH